PHARMING GROUP NV (PHARM.AS) Stock Analyst Ratings
Europe - AMS:PHARM - NL0010391025 - Common Stock
1.412 EUR
-0.04 (-2.75%)
ChartMill assigns a Buy % Consensus number of 89% to PHARM.AS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.95. This target is 37.97% above the current price.
PHARM.AS was analyzed by 14 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about PHARM.AS.
In the previous month the buy percentage consensus was at a similar level.
PHARM.AS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
PHARMING GROUP NV / PHARM.AS FAQ
What is the average price target for PHARMING GROUP NV (PHARM.AS) stock?
14 analysts have analysed PHARM.AS and the average price target is 1.95 EUR. This implies a price increase of 37.97% is expected in the next year compared to the current price of 1.412.
How do analysts rate PHARMING GROUP NV (PHARM.AS)?
The consensus rating for PHARMING GROUP NV (PHARM.AS) is 88.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for PHARMING GROUP NV stock?
The number of analysts covering PHARMING GROUP NV (PHARM.AS) is 14.